Sunday, 2 January 2022

Two studies provide good news for the antiviral drug remdesivir.


By BY GINA KOLATA from NYT Science https://ift.tt/31hp5jB
Posted by at
Labels:

No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)